Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors

Clinical trial NCT07058948 · RECRUITING

Trial details

NCT number: NCT07058948
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Cancers Radiotherapy Immune Checkpoint Inhibitor Lung Cancer

Start date: 2025-07-01
Primary completion: 2026-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.